Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,329 | 24,839 | 47,660 | 9,977 | 16,746 |
| TOTAL | $7,563 | $25,459 | $48,080 | $10,382 | $17,396 |
| Non-Current Assets | |||||
| PPE Net | 2 | 67 | 169 | 316 | 664 |
| Other Non-Current Assets | 370 | 1,349 | 1,990 | 2,410 | 300 |
| TOTAL | $372 | $1,416 | $2,159 | $2,726 | $964 |
| Total Assets | $7,935 | $26,875 | $50,239 | $13,108 | $18,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,230 | 1,192 | 3,725 | 3,106 | 2,755 |
| Accrued Expenses | 3,968 | 3,108 | 6,004 | 3,820 | 4,784 |
| TOTAL | $5,401 | $5,052 | $10,433 | $7,584 | $7,539 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 204 | 1,557 | 1,933 | 6,965 |
| TOTAL | $N/A | $204 | $1,557 | $1,933 | $6,965 |
| Total Liabilities | $5,401 | $5,256 | $11,990 | $9,517 | $14,504 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,448 | 9,545 | 9,491 | 6,132 | 4,596 |
| Common Shares | 96 | 95 | 95 | 46 | 39 |
| Retained earnings | -252,078 | -232,247 | -214,491 | -189,763 | -176,496 |
| TOTAL | $2,534 | $21,619 | $38,249 | $3,591 | $3,856 |
| Total Liabilities And Equity | $7,935 | $26,875 | $50,239 | $13,108 | $18,360 |